Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yashraj Biotechnology Limited has over two decades of experience supplying high-purity native and recombinant antigens as well as monoclonal/polyclonal antibodies to the global in-vitro diagnostic industry. Their products are widely used by leading diagnostic companies worldwide for assay development and quality control. The company also offers biobanking solutions including human biospecimens and advanced iPSC-based research tools. They do not conduct clinical trials themselves but enable clinical diagnostics through their reagents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yashraj Biotechnology Limited.